BLACK WEEKSBočice −15% · kompleti −10% · ostalo −5%s kodomBesplatna dostava u Njemačkoj od 200 €

Ova je stranica automatski prevedena i može sadržavati pogreške. Jeste li izvorni govornik? Rado ćemo primiti vaše povratne informacije i ispravke.Pošaljite povratne informacije

The Peptide Desk The Peptide Desk
Semaglutide, fotografija proizvoda

Laboratorijsko izvješće

PDF
99%
Čistoća
Testirano
Semaglutide 10mg
Laboratorij
Analiza Białek
Datum
October 2026
Rezultat
99% purity (10.30 mg measured)
Endotoksini
5.83 EU/vial
Br. narudžbe
Lozinka

Neovisno testirano, može se provjeriti lozinkom izravno u laboratoriju.

GLP-1

Semaglutide

GLP-1

Narudžba

Jedinična cijena - Besplatna dostava u Njemačkoj iznad 200 € tijekom akcije Black Weeks
  • DHL s praćenjem
  • Diskretno pakiranje

4.6 od 5 na Trustpilotu73 recenzija

Traženo i kao: Semaglutid · Sema

Dostupno i kao tableta: Semaglutide Oral →

Na prvi pogled

Semaglutide u brojkama

Ključni podaci iz našeg leksikona. Povucite točku po krivulji i pogledajte koliko, prema izračunu, ostaje nakon jedne doze.

Cijeli članak u leksikonu

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~7 days

Half-life ~7 days
After 14 days: 25 %
Day 750 %Day 1425 %Day 2112.5 %Day 353.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

~7days

Class
GLP-1 agonistsingle
Frequency
Once weeklysubcutaneous
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 50 mg6 sizes in the shop
  1. ~15 %

    Phase 3 study in obesity (STEP 1, ~15% weight reduction at 68 weeks) (opens in a new tab)

    Wilding et al., New England Journal of Medicine, 2021
  2. Cardiovascular study in obesity without diabetes (SELECT) (opens in a new tab)

    Lincoff et al., New England Journal of Medicine, 2023
  3. Cardiovascular study in type 2 diabetes (SUSTAIN-6) (opens in a new tab)

    Marso et al., New England Journal of Medicine, 2016

Znanje

Sve o Semaglutide

Detaljne informacije uskoro.

Dobro je imati

Što vam uz to treba

Bakteriostatska voda automatski se dodaje u košaricu. Štrcaljke i maramice jednim klikom.

Inzulinske štrcaljke

10 kom. · 5.50 €

Alkoholne maramice

50 kom. · 10 €

Koliko vode?

Jedinice na štrcaljki za veličinu vaše bočice.

Otvori kalkulator →

FAQ

Česta pitanja

Izvori za svaki odgovor: članak u leksikonu

Imate još pitanja?

Pišite nam, naš tim će vam pomoći.

Is Semaglutide approved?

Yes. ChEMBL lists Semaglutide with phase 4 as the highest phase and a first approval in 2017. As an injection it is given once a week, there is also a tablet (separate entry). The information here describes the state of research and is not a recommendation for use.

How does Semaglutide differ from Tirzepatide and Retatrutide?

The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide also on GIP, Retatrutide additionally on the glucagon receptor. In return Semaglutide has the longest series of trials in the group, with large outcome trials on heart, kidney and liver.

What did the weight trials show?

In STEP 1 weight fell by 14.9 percent on average after 68 weeks, by 2.4 percent on placebo. Half of the participants lost at least 15 percent. In STEP 4 those who switched to placebo after 20 weeks regained weight: 6.9 percent by week 68, while the other group lost a further 7.9 percent.

What is known about heart, kidney and liver?

In SELECT (cardiovascular disease, overweight without diabetes) there were 6.5 versus 8.0 percent major cardiovascular events. In FLOW (type 2 diabetes with kidney disease) the risk of major kidney events was 24 percent lower. In ESSENCE MASH resolved after 72 weeks in 62.9 percent, in 34.3 percent on placebo.

How high were the doses in trials?

The highest study dose was 16 mg per week in a phase 2 trial in type 2 diabetes. Compared with the lowest dose there, blood sugar fell barely more, weight somewhat more, but there were more side effects and discontinuations. In STEP UP a higher dose also brought more weight loss and more complaints. The entry describes the opposite as a principle: start low and only increase until an effect is noticeable. This is not a dosing recommendation.

Which side effects were seen?

Most often nausea and diarrhoea, mostly transient and mild to moderate. In STEP 1 4.5 percent stopped because of gastrointestinal effects, 0.8 percent on placebo. In SUSTAIN-6 complications of the retina occurred more often in type 2 diabetes. With the higher dose from STEP UP altered skin sensations were more common.

How long does Semaglutide stay in the body?

According to the label the half-life is about one week, Semaglutide is still in the blood for about five weeks after the last dose. More than 99 percent is bound to the blood protein albumin. A steady level is reached after four to five weeks of weekly dosing.

Usporedbe

Kako se uspoređuje

Povezano

Srodni proizvodi